logo
Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference

By AP News
Published - Nov 27, 2024, 09:04 AM ET
Last Updated - Dec 16, 2024, 05:11 PM EST

FOSTER CITY, Calif.--(BUSINESS WIRE)--Nov 27, 2024--

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that members of the management team are scheduled to participate in a fireside chat at the 7 th Annual Evercore ISI HealthCONx Conference, in Coral Gables, Florida on Wednesday, December 4, 2024, at 8:20 a.m. ET.

A webcast of the fireside chat will be available through the Investors and Media section of Geron’s website under Events following the presentation. The webcast will be archived and available for replay for a period of 30 days.

About Geron

Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO™ (imetelstat) is approved in the United States for the treatment of certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion dependent anemia. We are also conducting a pivotal Phase 3 clinical trial of imetelstat in JAK-inhibitor relapsed/refractory myelofibrosis (R/R MF), as well as studies in other hematologic malignancies. Inhibiting telomerase activity, which is increased in malignant stem and progenitor cells in the bone marrow, aims to potentially reduce proliferation and induce death of malignant cells. To learn more, visit www.geron.com or follow us on LinkedIn.

View source version on businesswire.com:https://www.businesswire.com/news/home/20241127952135/en/

CONTACT: Aron Feingold

Vice President, Investor Relations and Corporate CommunicationsKristen Kelleher

Associate Director, Investor Relations and Corporate Communicationsinvestor@geron.com

media@geron.com

KEYWORD: CALIFORNIA FLORIDA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: SCIENCE BIOTECHNOLOGY RESEARCH PHARMACEUTICAL ONCOLOGY HEALTH HOSPITALS CLINICAL TRIALS

SOURCE: Geron Corporation

Copyright Business Wire 2024.

Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
4.2 12182024